Cyclooctylamine in the prevention of experimental human influenza.
D000367:Age Factors; D000547:Amantadine / Q000494:pharmacology; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use*; D000917:Antibody Formation; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001835:Body Weight; D002986:Clinical Trials as Topic; D034242:Cyclooctanes; D003516:Cycloparaffins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D008297:Male; D009666:Nose; D009975:Orthomyxoviridae / Q000276:immunology / Q000302:isolation & purification; D010919:Placebos; D013183:Sputum / Q000276:immunology
D000588:Amines; D000998:Antiviral Agents; D034242:Cyclooctanes; D003516:Cycloparaffins; D010919:Placebos; C000540:cyclooctylamine; D000547:Amantadine